Zuzana Diamant (Former)
21 – 40 of 99
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
(
- Contribution to journal › Letter
-
Mark
An Algorithm for Strategic Continuation or Restriction of Asthma Medication Prior to Exercise Challenge Testing in Childhood Exercise Induced Bronchoconstriction
(
- Contribution to journal › Article
-
Mark
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
(
- Contribution to journal › Article
-
Mark
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses : EAACI task force on eicosanoids consensus report in times of COVID-19
(
- Contribution to journal › Article
-
Mark
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas
(
- Contribution to journal › Scientific review
-
Mark
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
(
- Contribution to journal › Article
-
Mark
Allergen provocation tests in respiratory research : building on 50 years of experience
(
- Contribution to journal › Article
- 2021
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
(
- Contribution to journal › Article
-
Mark
Vaccines and allergic reactions : The past, the current COVID-19 pandemic, and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Immune Profile in Patients With COVID-19 : Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome
(
- Contribution to journal › Article
-
Mark
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
(
- Contribution to journal › Letter
-
Mark
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025 : Results from Two Randomized Studies in Healthy Subjects
(
- Contribution to journal › Article
-
Mark
Allergen bronchoprovocation test : an important research tool supporting precision medicine
(
- Contribution to journal › Article
-
Mark
Editorial : Dealing with asthma during the turbulent times of coronavirus disease-2019
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Revisiting matrix metalloproteinase 12 : its role in pathophysiology of asthma and related pulmonary diseases
(
- Contribution to journal › Article
-
Mark
Asthma and severe acute respiratory syndrome coronavirus 2019 : current evidence and knowledge gaps
(
- Contribution to journal › Article
-
Mark
Use of fractional exhaled nitric oxide to guide the treatment of asthma an official american thoracic society clinical practice guideline
(
- Contribution to journal › Article
- 2020
-
Mark
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
(
- Contribution to journal › Scientific review
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
(
- Contribution to journal › Article